Metabolism refers to the chemical reaction involving preservation of the living state. It offers wide range of advantages which include blood circulation, breathing, and digestion of food and contraction of muscles. It has the provision of eliminating wastes from the body such as urine. This process helps in functioning of the nerves of the organism and brain and maintaining the body temperature.
This process follows pathway that starts with a number of series of chemical reactions in a specific molecule in a sequential manner and finishes with a product that goes through with the help of specific enzyme. Enzymes are the most important to metabolism process that allow the organism to make chemical reactions to convert this into required energy. Metabolic testing helps to measure the wellness and health of an individual. Metabolic testing is used to determine and diagnose diseases which include diabetes and cardiovascular disease such as hyper tension, abdominal obesity, glucose intolerance and dyslipidaemia.
In 2016, Centers for Disease Control and Prevention and World Health Organization (WHO) came together to launch an initiative “Global Hearts” that consist of various programmes to deal with metabolic diseases, cancer and cardiovascular diseases. This programme includes the controlling of unhealthy diets in health individuals and offered technical package for cardiovascular disease. These initiatives were aimed at fighting with non-communicable diseases and make such diseases visible so that preventive actions can be taken effectively.
According to the estimation of Centers for Disease Control and Prevention (CDC), approximately 34% of adult Americans are predicted to be suffering from metabolic syndrome.
Increasing health care expenditure, growing prevalence of lifestyle diseases such as diabetes and obesity, the rise in health care awareness, and technological advancements are witnessing the remarkable growth in the metabolic testing market. However, stringent regulatory policies and reimbursement issues are anticipated to hinder the market growth. In addition, expensive testing equipment and high cost of medical solution may restrict the growth of the market. On the other hand, numerous product launches and merger and acquisition in this field are the major factors that are providing opportunity for the further expansion of the market.
Geographically, the metabolic testing market is segmented on the basis of the region covering North America, Asia Pacific, Europe, and LAMEA. North America is expected to be dominant in the metabolic testing market owing to increasing prevalence of cardiovascular diseases and metabolic disorders and development of metabolic testing equipment and devices. In addition, well-established healthcare infrastructure in North American region is anticipated to positively influence the market over the forecast period.
Asia Pacific is predicted to be fastest growing market over the forecast period owing to the rising demand for qualitative medical solutions and improved standard of living.
Furthermore, rising research and development investment in healthcare industry with the help of government initiatives and steps took by private organizations is attributed to rise the market growth. Moreover, growing geriatric population and rise in awareness levels are the significant factor propelling the growth in the market.
Major key Players in the market are Parvo Medics, AEI Technologies, Inc., Microlife Medical Home Solutions, Inc., KORR Medical Technologies, Inc., General Electric Company, OSI Systems, Inc., Geratherm medical AG, MGC Diagnostic Corporation, CORTEX Biophysik GmbH, COSMED, and CareFusion Corporation.
In May 2017, a global leader GE Healthcare partnered with FitTrace, a global cloud-based company, to integrate the versatility and reliability of DXA technology of GE healthcare with the help of FitTrace. This collaboration was aimed at improving the performance of sports person or athletes and individual overall health by understanding metabolic disorders and body composition.
oVO2 Max Analysis
oBody Composition Analysis
oHuman Performance Testing
oDysmetabolic Syndrome X
oEcgs/Ekgs Attachable To CPET Systems
oBody Composition Analyzers
oSports Training Centers
oNorth America (U.S and Canada)
oEurope (Germany, France, Italy and Rest of Europe)
oAsia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)
oLAMEA (Brazil, Turkey, Saudi Arabia, South Africa and Rest of LAMEA)